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Vaccination Decisions
Holly O. Witteman,1,2,3,∗ Selma Chipenda Dansokho,2 Nicole Exe,4 Audrey Dupuis,5
Thierry Provencher,6 and Brian J. Zikmund-Fisher4,7,8,9
Many health-related decisions require choosing between two options, each with risks and
benefits. When presented with such tradeoffs, people often make choices that fail to align
with scientific evidence or with their own values. This study tested whether risk communi-
cation and values clarification methods could help parents and guardians make evidence-
based, values-congruent decisions about children’s influenza vaccinations. In 2013–2014 we
conducted an online 2×2 factorial experiment in which a diverse sample of U.S. parents and
guardians (n = 407) were randomly assigned to view either standard information about in-
fluenza vaccines or risk communication using absolute and incremental risk formats. Partic-
ipants were then either presented or not presented with an interactive values clarification
interface with constrained sliders and dynamic visual feedback. Participants randomized to
the risk communication condition combined with the values clarification interface were more
likely to indicate intentions to vaccinate (β = 2.10, t(399)= 2.63, p< 0.01). The effect was par-
ticularly notable among participants who had previously demonstrated less interest in having
their children vaccinated against influenza (β = –2.14, t(399) = –2.06, p < 0.05). When assess-
ing vaccination status reported by participants who agreed to participate in a follow-up study
six months later (n = 116), vaccination intentions significantly predicted vaccination status
(OR = 1.66, 95%CI (1.13, 2.44), p < 0.05) and rates of informed choice (OR = 1.51, 95%CI
(1.07, 2.13), p < 0.012), although there were no direct effects of experimental factors on vac-
cination rates. Qualitative analysis suggested that logistical barriers impeded immunization
rates. Risk communication and values clarification methods may contribute to increased vac-
cination intentions, which may, in turn, predict vaccination status if logistical barriers are also
addressed.
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1. INTRODUCTION
Many choices in the context of health require
choosing between two options in which both carry
an element of risk. When presented with such risk
tradeoffs, people can make choices that run contrary
to their preferences and values. These types of incon-
sistencies are especially apparent when probabilities
are small and when risks are laden with emotion.(1,2)
Previous research has documented this effect in mul-
tiple studies,(3,4) demonstrating that this difficulty in
making an evidence-based and values-congruent de-
cision is a robust and persistent phenomenon. By
values-congruent, we mean choices that align with
people’s stated values.
Health decision support tools such as patient
decision aids can support informed choices and in-
creased clarity of values.(5) However, more research
is needed on methods of shared decisionmaking(6)
that can not only help people better understand risks
and benefits, but also how their values relevant to
those risks and benefits determine what choice might
be best suited to them. Previous research has demon-
strated that particular design features of risk visu-
alizations and interactive online interfaces can help
people make more values-congruent choices when
faced with risk tradeoffs.(7,8) For example, in the
context of a hypothetical treatment for colon can-
cer, by using an interactive interface that makes
the tradeoffs of a decision apparent and explic-
itly shows people how their stated preferences im-
ply that one option is more in line with their val-
ues than the other, the proportion of study partic-
ipants who made incongruent choices was reduced
by 40%.(9)
In the present study, we applied similar methods
to vaccination decisions. Decisions about immuniza-
tion may be complex and involve many influences,(10)
including omission bias, meaning that people feel
more regret about a negative outcome from some-
thing they elected to do than from something they
elected not to do,(11) complex mental models,(12)
social networks,(13) social norms derived from in-
creasingly polarized online social groups,(14,15) and
other media influences(16–18) that may contribute to
vaccine hesitancy in developed countries.(19) Such
vaccine hesitancy may, in turn, be contributing to
population health outcomes such as outbreaks of
vaccine-preventable diseases(20) and to individual
health outcomes such as an increased rates of
seizures in children.(21)
Childhood influenza immunization offers an in-
teresting and important study context. Influenza vac-
cines first began to be recommended for healthy chil-
dren aged 6 to 23 months in the United States in
the 2004–2005 season. In the following years, the
recommendations expanded by age groups until the
vaccine was recommended in the 2008–2009 season
for all children, aged 6 months to 17 years.(22) In
2012, approximately half the children in the United
States were vaccinated against influenza; yet 90% of
deaths occurred among unvaccinated children. Ap-
proximately 40% of the children who died had no
known health concerns.(23) In addition to the need to
reduce mortality and burden of illness among chil-
dren, increased immunization of children could also
reduce the burden of influenza in the population as a
whole.(24)
Unlike some other health decisions, public in-
formation about influenza immunization does not
typically include understandable numerical risk es-
timates (e.g., see information for the public from
the Centers for Disease Control and Prevention).(25)
It can be difficult even for highly numerate peo-
ple to develop a clear, well-informed sense of
the overall risk-benefit balance. Parental concerns
about the effectiveness and potential side effects
of influenza vaccines have been noted as key rea-
sons for choosing not to have their children vac-
cinated against influenza,(26,27) making the lack of
clear, comprehensible information an important
concern.
Furthermore, relatively little work has been
done to help parents and guardians understand how
immunization decisions for their children relate to
their parental values. The process of values clar-
ification, that is, of sorting out what is important
to an individual relevant to a decision,(28) is a key
step in making an informed choice.(29) By informed
choice we mean a decision that meets key criteria
of normative frameworks of health decision qual-
ity. Specifically, the decision must be based on rel-
evant knowledge, be aligned with the values of the
decisionmaker, and be behaviorally implemented,
meaning that the decisionmaker follows through on
the decision.(30,31) There is a need to better bridge
the information available to parents because infor-
mation sources that are critical of vaccines tend
to focus more on values, while official information
sources focus more on communicating about risks
and benefits.(12)
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The overall objective of this study was to better
understand how to help people make more informed
choices when presented with risk-benefit tradeoffs.
To pursue this aim, we used an experimental de-
sign to test methods that might help parents under-
stand the risks associated with immunizing and not
immunizing their children against influenza, grasp
the tradeoffs inherent in the decision, visualize how
their individual values relate to their options, and
make choices that align with their values. Avail-
able statistics about the risks and benefits of flu
vaccines—for example, the fact that, in the 2012–
2013 flu season, 90% of influenza-related pediatric
deaths occurred among unvaccinated children(23)—
suggest that, for most parents, the benefits of chil-
dren’s influenza immunization outweigh the risks.
Therefore, by helping people understand the differ-
ent statistics for vaccinated and unvaccinated chil-
dren and also guiding them through the process of
aligning their choices with their values relevant to
the decision, we hypothesized that we would ob-
serve higher intentions among participants to vacci-
nate their children against influenza and thus higher
rates of vaccination.
2. METHODS
2.1. Recruitment
During the months of November and Decem-
ber 2013, we invited members of Amazon’s Mechan-
ical Turk (MTurk)(32) to take an online survey about
flu vaccines for children. To be eligible in the study,
participants had to live in the United States, be 18
years or older, and be a parent or guardian who
makes medical decisions for at least one child aged
6 months to 18 years. In addition, their child could
not yet have received a flu vaccine in the current flu
season nor could the child have medical reasons to
avoid such a vaccine. In other words, both through
timing and through inclusion and exclusion criteria,
we targeted parents of children who were likely to
be undecided about vaccinating their children against
influenza. Participants were compensated $0.50 for
completing the first survey.
In June 2014, after flu season had ended, we
invited participants who had completed the first
survey to complete a follow-up survey. To recruit
participants to the follow-up study, we sent a bonus
payment ($0.10) along with a message inviting them
to complete a brief follow-up questionnaire. After
one week, we sent a single reminder to those who
had yet to reply, along with a small additional bonus
payment ($0.01). Participants who completed the
follow-up questionnaire were therefore compen-
sated between $0.60 and $0.61, bringing the total
compensation across both surveys to between $0.60
or $0.61 (for participants who completed only the
first survey and received the follow-up invitation and
bonus payment) and $1.10 or $1.11 (for participants
who completed the follow-up survey).
The study was deemed exempt by the Institu-
tional Review Board as anonymous survey research.
Before clicking to begin both the original and follow-
up survey, all participants viewed a consent page in
which they were informed that the survey would in-
volve learning about flu vaccines for children. The
consent page included an explicit statement to the ef-
fect that the study was not funded by or associated
with any pharmaceutical company, and that we were
interested in participants’ honest opinions.
2.2. Design of Experiment
We conducted a 2×2 factorial experiment. The
first factor, Risk Communication, randomly varied
between a Control condition, for which we presented
standard information about influenza immunization
copied directly from the Centers for Disease Control
and Prevention with their formatting,(25) and a Risk
Communication condition, in which we presented nu-
merical information and graphics showing absolute
risk estimates of the risks and benefits of flu vac-
cines for children, including rates of pediatric deaths
in 2012–2013 due to influenza and side effects of flu
vaccines among children in the United States. We
also described each benefit or risk briefly, for ex-
ample, explaining Guillain-Barre´ Syndrome and its
typical progression as simply and clearly as possible.
We derived our estimates from published models and
epidemiological studies.(23,33–35) As much as possible,
we based our calculations on publications that were
freely available (meaning not behind paywalls) in or-
der to facilitate transparency. For participants ran-
domized to the Risk Communication condition, we
provided links to our sources after participants had
completed the survey. Estimates were presented as
rates per 10 million children; we further contextual-
ized this number by informing participants that there
are approximately 65 million children in the United
States. Using a consistent denominator helps peo-
ple better understand and compare risk estimates.(36)
When presenting data about children’s deaths due to
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influenza, we also included icon arrays(7) to help par-
ticipants better understand the differences in death
rates between groups of vaccinated and unvaccinated
children. We presented the benefits of the pediatric
influenza vaccine first (that is, avoiding the risks of
influenza disease) followed by the risks of the vac-
cine. Specifically, we first presented tables of num-
bers for both vaccinated and unvaccinated children,
for example: “Out of every 10 million children vac-
cinated against the flu, about 86 will be hospitalized
because of the flu or its complications. Out of every
10 million children NOT vaccinated against the flu,
about 367 will be hospitalized because of the flu or
its complications” (emphasis in original). These were
followed by summaries in which we calculated the
differences for participants, e.g.: “For every 10 mil-
lion children who are vaccinated against the flu,
about 281 children will avoid being hospitalized be-
cause of the flu or its complications” (emphasis in
original). This technique, in which we do the arith-
metic for people to highlight the incremental risk dif-
ference, has been associated with better outcomes
in other decision contexts.(8,37) After presenting the
benefits and risks separately, we presented a sum-
mary table of incremental benefits and risks side by
side. The full presentation can be seen in Appendix 1.
The second factor, Values Clarification, ran-
domly varied between a control condition (No
Values Clarification condition) and a Values Clarifi-
cation condition in which participants were asked to
use sliders to indicate the importance of competing
risks, such as avoiding death due to flu and avoiding
a serious complication such as Guillain-Barre´ Syn-
drome from the vaccine. This use of the term Values
Clarification represents the current definition in use
in the field of shared decisionmaking.(38) The sliders
were constrained such that as a participant moved
one slider in one direction, the other automatically
moved in the other direction, making the tradeoffs
in the decision explicit and salient. We also displayed
a recommended option via vertical bars that moved
dynamically based on a simple linear function of the
slider positions. See Fig. 1 for an image of the Values
Clarification interface.
2.3. Study Procedure
Participants began the study by reading about
influenza. Following this general information,
they were exposed to either the Control or Risk
Communication presentation of information. Par-
ticipants who had been randomized to the Values
Clarification condition were then asked to complete
a brief values clarification exercise, whereas those
randomized to No Values Clarification proceeded
directly to the portion of the survey in which we
assessed outcomes. (See Fig. 2 for a study flow
diagram.) We then collected participants’ responses
to our primary outcome, followed by other questions
that included a secondary outcome, moderator and
sociodemographic questions. We asked participants
to think of their child when answering the questions.
Participants with more than one child within the
eligible age range were randomly instructed to think
of their child who had either the earliest or latest
birthday in the calendar year.
At the conclusion of the survey, participants
were provided with a brief list of resources for learn-
ing more about flu vaccines, including where they
could get their child vaccinated.
Approximately six months later, after flu season
had finished, people who participated in the follow-
up study were asked whether or not they got their
child vaccinated. We also asked them for their opin-
ion about the risk-benefit balance of influenza immu-
nization, to briefly state why they did or did not get
their child vaccinated, and to answer questions that
assessed their retained gist knowledge(39) about the
risks and benefits of flu vaccines.
2.4. Measures
2.4.1. Independent Variables
There were two independent variables in the
experimental design, as described in the previous
section. The variable Risk Communication describes
whether study participants were presented with
absolute risk and benefit estimates of influenza im-
munization for children (Risk Communication con-
dition) or standard information copied directly from
the website of the Centers for Disease Control (Con-
trol condition). The variable Values Clarification de-
scribes whether or not participants were asked to
complete a values clarification exercise designed to
help them clarify what is important to them and align
their decision with their values (Values Clarification
condition vs. No Values Clarification condition).
2.4.2. Primary Proximal Outcome (Original Survey):
Vaccination Intentions
The primary outcome in this study was Vaccina-
tion Intentions, a measure of participants’ intentions
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Fig. 1. Values clarification interface.
to vaccinate their child against influenza. The intro-
ductory text for this outcome read: “You may or may
not have made a decision about whether or not to
get a flu vaccine for your child this year. We would
like to know your feelings about this decision at this
moment.” Participants were then asked to respond
to the question, “Based on how you feel about this
decision right now, would you say you will choose
to,” on a nine-point Likert scale, with anchors, “Defi-
nitely GETmy child a flu vaccine this year,” (value 4)
on the left of the scale and, “Definitely NOT get my
child a flu vaccine this year,” (value −4) on the right
(capitalization in original). Participants did not see
the numbers associated with the response options,
only a row of radio buttons.
2.4.3. Primary Distal Outcome (Follow-Up Survey):
Vaccination Status
For the subset of participants who completed
the follow-up survey, we also collected a primary
distal outcome: Vaccination Status. Participants
were asked: “In our original survey in November/
December 2013, we gave you information about
flu vaccines for children and asked you whether or
not you thought you would get a flu vaccine for
your child. Please tell us: Did your child get a flu
vaccine since you took the last survey in November/
December 2013?” Response options were, “Yes,”
“No,” or “Not sure/Can’t remember.” Parental
report about children’s influenza vaccination status
is an imperfect but acceptably valid measure of
such status, particularly in a study such as ours,
which occurred entirely online. Previous studies
have documented the sensitivity and specificity of
self-report in this context as 88% and 90% in one
study(40) and as 91% and 82% in another.(41)
2.4.4. Secondary Outcome (Original Survey):
Values Congruence
We also considered a secondary outcome in this
study: Values Congruence. To assess this, near the
end of the first survey, we asked all participants a
question based on previous research about attitudes
in the United States about childhood vaccination,(42)
“Which of the following statements best represents
your opinion (choose one): When it comes to flu
vaccines for children . . . ” with five possible re-
sponse options, “The benefits of the vaccine strongly
outweigh the risks,” “The benefits of the vaccine
slightly outweigh the risks,” “The benefits and
risks of the vaccine are about equal,” “The risks of
the vaccine slightly outweigh the benefits,” or “The
risks of the vaccine strongly outweigh the benefits.”
To measure participants’ values congruence, we
compared their response about the risk-benefit bal-
ance to their vaccination intentions and noted each
participant’s responses as either congruent or not.
We assigned the top two points on the vaccination
intentions scale (top point = definitely get my child
the vaccine) as indicating strong intentions toward
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Fig. 2. Study flow.
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vaccination and thus congruent with the first
risk-benefit balance statement (benefits strongly
outweigh risks), the third and fourth top points as
indicating weak intentions toward vaccination and
thus congruent with the second statement (benefits
slightly outweigh risks), the middle point of the vac-
cination intentions measure as indicating neutrality
and thus congruent with the third statement (benefits
and risks about equal), the sixth and seventh points
as indicating weak intentions against vaccination
and thus congruent with the fourth statement (risks
slightly outweigh benefits), and the bottom two
points on the vaccination intentions scale (bottom
point = definitely not get my child the vaccine)
as indicating strong intentions against vaccination
and thus congruent with the fifth statement (risks
strongly outweigh benefits).
2.4.5. Secondary Outcome (Follow-Up Survey):
Informed Choice
We used a measure of informed choice accord-
ing to the framework developed by Marteau, Dor-
mandy, and Michie,(30,31) which stipulates that an in-
formed choice must satisfy three criteria. First, it
must be based on an adequate understanding of rele-
vant knowledge. Second, it must be aligned with the
values of the decisionmaker. Third, it must be behav-
iorally implemented, meaning that the person follows
through on the decision and implements the action
chosen. We collected data about participants’ knowl-
edge only in the follow-up survey to avoid a knowl-
edge test influencing the effects of the intervention in
the original study.
To assess knowledge, we listed each of the 11
risks and benefits that had been presented in the orig-
inal study and asked participants to indicate whether
they thought each event was “more likely for chil-
dren who are vaccinated against flu, just as likely
for all children, whether or not they are vaccinated
against flu, or more likely for children who are NOT
vaccinated against flu” (capitalization original). Al-
though we collected data for all 11 items, all of which
had been clearly presented in the Risk Communica-
tion condition, for the measure of informed choice,
we used only the four items that were explicitly pre-
sented in the Control condition. Participants who had
three or four items correct (i.e., who were at or above
the median number of correct answers) were deemed
to have adequate knowledge. It should be noted that
there was almost perfect overlap between the lat-
ter participants and those who scored at or above
median on the 11 items, but we defined adequate
knowledge based on the subset of four items to en-
sure that all participants had as fair a chance as pos-
sible to give correct answers. See Appendix 2 for the
11 items, with the subset of four items indicated.
To assess alignment with values, we used a sim-
ilar approach as that for values congruence. Partici-
pants who had indicated in the original survey that
they thought that the benefits of influenza vaccines
strongly or somewhat outweighed the risks were clas-
sified as valuing vaccinating. Thus, the distinction be-
tween this measure and values congruence is that
the latter is based on participants’ decision intentions
whereas the former is based on their actual deci-
sions. Therefore, if such a participant indicated in the
follow-up survey that he or she had gotten the partic-
ipant’s child vaccinated, we assessed that as a values-
congruent and behaviorally implemented decision.
Participants who had indicated that they felt that
the risks and benefits were equal, or that the risks
outweighed the benefits somewhat or strongly, were
classified as valuing not vaccinating. If these partici-
pants indicated that they had not gotten their child
vaccinated, we assessed that as a values-congruent
and behaviorally implemented decision.
We then defined participants who had made an
informed choice as those who had adequate knowl-
edge and who had made decisions that were both
values-congruent and behaviorally implemented.
2.4.6. Secondary Outcome (Follow-Up Survey):
Reasons for Vaccinating or Not Vaccinating
The third question in the follow-up survey was
an open text field with the question wording: “Please
tell us (briefly) why did your child did or did not get
the flu vaccine. Remember: We are interested in your
honest answers.”
2.4.7. Moderator: Decision History
As an indicator of participants’ overall attitudes
toward flu vaccines for children, in the original sur-
vey, we asked about their decision history: “Which
of the following statement best describes your de-
cisions about flu vaccines for your child(ren) in the
past 5 years? If you have not been a parent/guardian
for at least 5 years, answer for the number of years
you have been a parent/guardian,” with response op-
tions, “I chose to get my child(ren) a flu vaccine ev-
ery year,” “I chose to give my child(ren) a flu vaccine
some years,” and, “I never chose to get my child(ren)
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a flu vaccine.” For analyses, we combined the first
two statements to create a dichotomous variable in-
dicating whether or not the participant had previ-
ously demonstrated interest in immunizing his or her
child(ren) against influenza.
2.5. Analyses
Analysis of the primary proximal outcomeVacci-
nation Intentionswas conducted as a linear regression
with both experimental factors as well as the moder-
ator entered into the model. Values Congruence used
the samemodel components but was analyzed as a lo-
gistic regression. Both distal outcomes, primary Vac-
cination Status and secondary Informed Choice, were
analyzed via logistic regression with both experimen-
tal factors entered into the model as well as Vaccina-
tion Intentions as a moderator.
We conducted a thematic analysis of the re-
sponses to our question about why the participants
had chosen to get or not to get their child vacci-
nated. Two authors (HOW, SCD) collaboratively
developed the coding scheme and then indepen-
dently thematically coded each response inMicrosoft
Excel,(43) assigning one to three themes per response
as needed. Discrepancies were resolved by discussion
until we reached consensus. We summarized the fre-
quency of each theme and compared frequencies of
themes between participants who chose to vaccinate
and those who chose not to vaccinate their child. We
also analyzed frequencies of themes for parents and
guardians who chose to have or not to have their
child vaccinated against influenza compared to their
previously stated intentions in the original survey.
We conducted these analyses via Fisher’s exact tests
due to the presence of cells in the contingency tables
with frequencies less than 5.
In all regressions, we examined all potential
main effects and interactions. The alpha level for
primary outcomes was 0.05. For the four analyses
of secondary variables, we applied a Bonferroni
correction to reduce the likelihood of family-wise
type 1 error, resulting in an alpha level of 0.012 for
these outcomes. All analyses were conducted in R,
version 3.0.2.(44)
3. RESULTS
3.1. Study Participants
Of the 666 people who clicked on the survey
and answered the eligibility questions, 579 were
eligible to participate in the study. Of these, 412
(71%) completed the survey. The median time to
complete the full survey was 14 minutes (interquar-
tile range 10–19 minutes). We excluded from anal-
ysis participants who completed the full survey in
less than 5 minutes, as this speed suggested that they
might not have been paying attention to the content.
Five participants were excluded on this basis. Thus,
the final sample for analysis comprised responses
from 407 participants (70% of eligible participants).
Participants were predominantly female and half
of participants were between the ages of 28 and
41. Participants’ ethnicities and races were diverse,
though not completely representative of the U.S.
population. Nearly half had no college degree. See
Table I for details of study participant characteristics.
We invited 406 of the original 407 participants
to participate in the follow-up survey. One partic-
ipant was excluded because he or she had not en-
tered a code in the original survey that would al-
low us to link responses between the two surveys for
that participant. Of the 406 people invited, 116 (29%)
completed the follow-up survey. They were generally
representative of the original group. The only char-
acteristic that showed any lack of representativeness
was age: participants who completed the follow-up
survey were slightly older as a group (mean age 37,
SD 9) compared to those who did not (mean age 35,
SD 9, β = 2.99, t(405) = 4.92, p < 0.05). See Table I
for further details.
A randomization check showed that nearly all
of the various participant characteristics were evenly
distributed across the experimental factors (ps >
0.05). However, one characteristic demonstrated
unbalanced distribution. Participants who identified
as Asian or Asian American were unequally divided
on the Values Clarification factor. In the first survey,
three of these participants were randomized to the
Values Clarification condition; the remaining 15
were not (Fisher’s exact test: odds ratio 5.4, 95%
CI (1.5, 29.5), p < 0.05). Similarly, in the follow-up
study, a randomization check showed that all six par-
ticipants who identified as Asian or Asian American
came from the group of 15 who were not randomized
to Values Clarification (Fisher’s exact test p < 0.05).
As these participants represented a fraction of our
sample and race was not a planned moderating factor
in our analyses, this imbalance did not change our
analytical approach. Although participants who com-
pleted the follow-up study were, as indicated above,
older as a group, their ages did not vary significantly
between the study arms to which they had originally
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Table I. Study Participant Characteristics
Characteristic
Main Survey
(N = 407)
Follow-Up Survey
(N = 116)
Test of
Differences
(Note 1)
Sociodemographic Characteristics of Participants
Age: Mean (SD) 35 (9) 37 (9) p < 0.05
Gender: N (%) Female 257 (63%) 71 (61%) ns
Male 149 (37%) 45 (39%)
Ethnicity: N (%) Hispanic 33 (8%) 5 (4%) ns
Middle Eastern 1 (0.2%) 0 (0%) ns
Race: N (%) African American or black 42 (10%) 12 (10%) ns
American Indian or Alaska Native 11 (3%) 1 (1%) ns
Asian or Asian American 18 (4%) 6 (5%) ns
Pacific Islander or Native
Hawaiian
0 (0%) 0 (0%) ns
White or Caucasian 324 (80%) 94 (81%) ns
Other 5 (1%) 0 (0%) ns
Highest education level None 0 (0%) 0 (0%) ns (Note 2)
reached: N (%) Elementary school 0 (0%) 0 (0%)
Some high school, but no diploma 6 (1%) 2 (2%)
High school (diploma or GED) 42 (10%) 9 (8%)
Trade school 11 (3%) 1 (1%)
Some college, but no degree 133 (33%) 30 (26%)
Associate’s degree (AA, AS, etc.) 58 (14%) 20 (17%)
Bachelor’s degree (BS, BA, etc.) 113 (28%) 36 (31%)
Master’s degree (MA, MPH, etc.) 35 (9%) 12 (10%)
Doctoral/professional degree
(PhD, MD, etc.)
9 (2%) 6 (5%)
Characteristics of Child
Age of child: N (%) 6–23 months old 70 (17%) 21 (18%) ns
2–4 years old 114 (28%) 32 (28%)
5–11 years old 140 (34%) 36 (31%)
12–17 years old 83 (20%) 27 (23%)
Previous Vaccination Decisions
Child has received: N (%) All standard vaccines, on standard
schedule
258 (64%) 76 (66%) ns
Selected vaccines, on standard
schedule
54 (13%) 16 (14%)
All standard vaccines, on alternate
schedule
23 (6%) 8 (7%)
Selected vaccines, on alternate
schedule
39 (10%) 10 (9%)
Not applicable (no vaccines) 31 (8%) 5 (4%)
In the past 5 years, participant Every year 80 (20%) 27 (23%) ns
chose to get a flu vaccine for Some years 159 (39%) 47 (41%)
her/his child: N (%) Never 168 (41%) 42 (46%)
Vaccine Access
Flu vaccine available for child Yes 237 (58%) 69 (59%) ns
without any out-of-pocket No 84 (21%) 24 (21%)
costs: N (%) Not sure 85 (21%) 23 (20%)
Participant knows where to get Yes 385 (95%) 108 (94%) ns
the flu vaccine: N (%) No 13 (3%) 4 (3%)
Not sure 8 (2%) 3 (3%)
Other Individual Difference Measures
Subjective numeracy (out of possible 6 to 48): Median (IQR) 38 (11) 38 (11) ns
Beliefs about medicines (out of possible 8 to 40): Median (IQR) 24 (8) 24 (9) ns
Note 1: Differences tested via linear regression (continuous variables), chi-squared tests (categorical variables with 5 or more participants
per cell) or Fisher’s exact tests (categorical variables for which one or more cells had fewer than 5 participants), comparing participants in
original survey who did and did not participate in follow-up survey.
Note 2: Fisher’s exact test with simulated p-value converging to p = 0.05 after each of 104, 105, and 106 simulations.
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been randomly assigned, nor did age demonstrate
any tendencies toward influencing any of the
outcomes.
3.2. Outcomes
Analyzing participants’ vaccination intentions,
we observed a main effect of participants’ decision
history. This moderator predicted their intentions (β
= 2.51, t(399)= 4.92, p< 0.001), meaning that partici-
pants who had previously decided to vaccinate one or
more children against influenza were more inclined
to do so again. We also observed a two-way interac-
tion between Risk Communication and Values Clar-
ification in their association with Vaccination Inten-
tions (β = 2.10, t(399) = 2.63, p < 0.01) in which
neither the Risk Communication condition nor the
Values Clarification condition alone appeared to in-
crease intentions significantly; however, when com-
bined together, they increased intentions from the
control condition by nearly one point on the nine-
point scale (see Fig. 3A). In addition, we observed a
three-way interaction between all three predictors (β
= –2.14, t(399) = –2.06, p < 0.05), which suggested
that while Risk Communication alone was more or
less sufficient to help people who had vaccinated
their children against flu within the past five years
choose to do so again, the combination of Risk Com-
munication and Values Clarification was especially
important for participants who had not recently vac-
cinated their children against influenza (see Fig. 3B).
Rates of values congruence varied according to
the experimental and moderating factors, ranging
from 34% to 64% of participants stating vaccination
intentions that were congruent with their stated val-
ues (see Table II for details). Among the two groups
of participants who had and who had not previously
gotten their child vaccinated against flu, the highest
rates of values congruence were observed in the Risk
Communication and Values Clarification conditions.
However, the rates of values congruence did not vary
statistically significantly. We observed no main ef-
fects nor any interactions.
Examining children’s vaccination status as re-
ported in the follow-up survey, we observed that nei-
ther experimental factor demonstrated any effects,
nor were there any significant interactions. However,
the moderator in the model, Vaccination Intentions,
showed a main effect (OR = 1.66, 95% CI (1.13,
2.44), p < 0.05). Overall, 44 participants (38%) re-
ported having their child vaccinated against flu. Dur-
ing the same time period as this study, approximately
25% of children who had yet to be vaccinated against
flu in the United States received a vaccine.(45) Al-
though the national rate offers some context for our
findings, it is important to note that participants in
this study were not a random sample and therefore,
due to the strong potential for selection bias, these
rates should not be directly compared against each
other. Fig. 4 displays details of patterns of reported
vaccination. As can be seen in the figure, even among
participants with the strongest intentions to get their
child vaccinated against influenza, nearly two in five
did not follow through on that intention.
Overall, 45/116 (39%) of participants made an
informed choice. Similar to vaccination status, the
only significant predictor of informed choice was pre-
vious vaccination intentions, which demonstrated a
main effect in which stronger intentions toward vac-
cination were associated with increased rates of in-
formed choice (OR = 1.51, 95% CI (1.07, 2.13), p <
0.012). See Table III for more details regarding in-
formed choice.
Examining participants’ free text responses to
the question of why they chose to get their child
vaccinated or not, we observed two broad themes:
Beliefs and Logistics, with five and three subthemes,
respectively. The theme Beliefs has to do with partic-
ipants’ beliefs about the vaccine, immunity, the flu,
and how the decision to vaccinate their child or not
might impact on different people. The theme Logis-
tics has to do with circumstances in people’s lives that
may either facilitate or impede them from having
their child vaccinated against flu. See Table IV for
a full description of themes and subthemes, sample
quotes, and frequencies of each theme and sub-
theme. Themes were not exclusive, meaning that a
single response could be coded with multiple themes
and subthemes. One hundred and twelve out of the
116 participants (97%) provided a comment that was
coded with at least one and up to three of our defined
subthemes. Analyzing the frequencies of each theme,
we observed that participants who did get their child
vaccinated almost exclusively cited Beliefs as their
reason to have their child vaccinated. Within this
group, there were 39/43 participants (91%) whose
responses contained only the theme Beliefs, 2/43 par-
ticipants (5%) whose responses contained only the
theme Logistics, and 2/43 participants (5%) whose
responses contained both themes. Among partici-
pants who did not get their child vaccinated, Beliefs
remained the more frequent theme but the theme
Logistics also appeared frequently. Within this
group, there were 41/69 participants (59%) whose
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Fig. 3. Vaccination intentions by study arm and decision history.
S = standard risk presentation format; RC = risk communication format; VC = values clarification interface.
Response scale ranged from 4 (“definitely GET my child a flu vaccine this year”) to –4 (“definitely NOT get my child a flu vaccine this
year”)
Table II. Number of Participants with Values-Congruent Responses (Original Survey)
S S + VC RC RC + VC
Decision History: No Flu Vaccines 19/45 (42%) 12/35 (34%) 20/43 (47%) 22/45 (49%)
Decision History: Flu Vaccines 23/58 (40%) 31/55 (56%) 30/56 (54%) 45/70 (64%)
S = standard risk presentation format; RC = risk communication format; VC = values clarification interface.
responses contained only the theme Beliefs, 23/69
participants (33%) whose responses contained only
the theme Logistics, and 5/69 participants (7%)
whose responses contained both themes. Compar-
ing people who did and did not have their child
vaccinated, the patterns of theme frequencies were
significantly different from each other (Fisher’s exact
p < 0.001).
To incorporate participants’ previously stated
vaccination intentions into these analyses, we con-
sidered any participant who had marked one of
the upper four points on the nine-point vaccination
intentions scale as intending to vaccinate his or her
child and any participant who indicated his or her
intentions as neutral or lower as not intending to
vaccinate the participant’s child. Table V shows
the distribution of themes among the groups whose
actions did or did not align with their original
intentions. All six participants who did not intend
to vaccinate their child yet did so anyway indicated
a reason that had to do with Beliefs. In contrast,
among the 29 participants who did not vaccinate
their child as intended, Logistics was the domi-
nant theme. The patterns of theme frequencies
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Fig. 4. Reported vaccination status by study arm and vaccination intentions.
S = standard risk presentation format; RC = risk communication format; VC = values clarification interface.
differed significantly between groups (Fisher’s exact
p < 0.001).
4. DISCUSSION
4.1. Principal Findings
In this study, we examined the effects of risk
communication methods that clearly present numer-
ical estimates of the risks and benefits of influenza
vaccines for children along with values clarification
methods intended to help people understand which
option is likely to be best aligned with what matters
to them. Our results suggest that the combination
of these two approaches is most effective for en-
couraging intentions to vaccinate, particularly for
parents and guardians who may be more hesitant
to vaccinate their children against influenza. The
effects of our experimental factors did not directly
influence vaccination rates in our small follow-up
sample. However, our results demonstrated that
vaccination intentions are associated with increased
vaccination rates as well as rates of informed choice.
Previous studies in the context of vaccination
have demonstrated that vaccination intentions are
associated with vaccination behaviors.(11) Therefore,
given that our experimental factors are associated
with increased intentions, methods of risk communi-
cation and values clarification may be promising for
further research about encouraging informed choice
about vaccination.
Our results further demonstrated that while
parents and guardians who initially had little to no
intention to vaccinate their child against flu may
sometimes change their mind in favor of vaccination,
the primary gap between intentions and actions was
among parents and guardians who intended to vac-
cinate their child but encountered logistical barriers
such as access and affordability of vaccines. Future
research will require more focus on the process and
mechanisms of moving intentions into action in this
context. For example, it has been demonstrated that
adults make significant use of options to receive
vaccines outside of medical clinics(46) and clinic
hours.(47) Schools may serve as a similarly accessible
site for children’s vaccinations.(48) Cost should not
be ignored as a potential barrier; however, it should
be noted that even when vaccines against influenza
are widely available at no out-of-pocket cost to
parents or guardians, uptake may remain low.(49)
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Table III. Informed Choice (Follow-Up Survey)
Components of Informed Choice
Participants with adequate
knowledge
Participants who made
values-congruent,
behaviorally implemented
decisions
Participants who made an
informed choice
Overall (n = 116)
72 (62%) 68 (59%) 45 (39%)
Study Arm
S (n = 35) 17 (49%) 24 (69%) 13 (37%)
S + VC (n = 24) 13 (54%) 15 (63%) 7 (29%)
RC (n = 25) 22 (88%) 12 (48%) 12 (48%)
RC + VC (n = 32) 20 (63%) 17 (53%) 13 (40%)
Vaccination Intentions
Strong intentions against
vaccinating (n = 21)
8 (38%) 18 (86%) 6 (29%)
Weak intentions against
vaccinating (n = 11)
3 (27%) 6 (55%) 1 (9%)
Neutral (n = 14) 9 (64%) 6 (43%) 4 (29%)
Weak intentions toward
vaccinating (n = 28)
20 (71%) 13 (46%) 11 (39%)
Strong intentions toward
vaccinating (n = 42)
32 (76%) 25 (60%) 23 (55%)
S = standard risk presentation format; RC = risk communication format; VC = values clarification interface.
Similar to our findings, previous studies have
demonstrated that patient decision aids designed
to help parents and guardians make informed
choices about routine childhood vaccines are
associated with increased knowledge, reduced deci-
sional conflict,(50,51) more positive attitudes toward
vaccination,(52) and increased uptake of standard
vaccines on the recommended schedule.(11) These
findings, together with ours, suggest that supporting
parents and guardians in the process of making
informed choices about vaccinating their children
is a promising approach. In contrast, a recent study
suggests that participatory decisionmaking may not
be appropriate to the context of vaccination. The
findings of this observational study of conversations
between parents and health-care providers demon-
strated that when health-care professionals linguisti-
cally framed whether or not to vaccinate as a decision
to make (vs. a presumed action), parents were less
likely to choose to vaccinate their children.(53)
However, this study did not include an analysis
of whether or not health-care providers explicitly
drew on parents’ values to make recommendations,
and the analysis did not distinguish between shared
decisionmaking and leaving the decision wholly up
to the parents or guardians with no decision-making
participation on the part of the health-care provider.
Recommendations for health-care providers to
address vaccine hesitancy are to educate parents
more thoroughly about reasons to vaccinate their
children, correct misinformation, and consider
drawing on the power of narrative.(54,55) A trial of
a video- and text-based educational intervention
for vaccine-hesitant parents that included personal
accounts by parents whose children contracted
vaccine-preventable diseases found that such an
intervention was associated with more favorable at-
titudes toward vaccination—according to behavioral
theory, a predictor of behavioral intentions(56)—but
also did not change behavior regarding standard
childhood vaccines.(57)
Our study suggests that the combination of risk
communication and values clarification methods
designed specifically to support well-informed,
values-congruent decisions may be particularly
important when seeking to help vaccine-hesitant
parents and guardians make fully informed deci-
sions. We note that the risk communication methods
did not clearly prioritize certain risks or benefits,
and the values clarification method in this study
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Table IV. Themes (Follow-Up Survey)
Theme frequency among:
Theme Description Sample quotes
Participants who
vaccinated their
child against flu
(n = 44)
Participants who did
not vaccinate
their child against
flu (n = 70)
Beliefs Comments that demonstrated the influence of the participant’s beliefs,
feelings, or attitude on his or her decision to vaccinate or not vaccinate
the participant’s child against flu
41 (93%) 46 (66%)
Beliefs: child Beliefs about the
impact of
vaccinating or not
on the child
Did not vaccinate: “I don’t get the flu
vaccine for my children or myself
because in my own experience, getting
the vaccine has always made me actually
get the flu, so I don’t want to have that
same thing happen for my children.”
Vaccinated: “I did not want my child to
become ill and miss many school days.”
34 (77%) 35 (50%)
Beliefs: family Beliefs about the
impact the child’s
vaccination status
on the family
Vaccinated: “I have a large family, with a
lot of family gatherings. Some people in
my family have sensitive health issues. If
any of us gets the flu, we may endanger
someone else in the family. So we all get
shots.”
Did not vaccinate: “They [vaccines]
genetically alter the person and can affect
that person’s offspring.” (this comment
also coded as Beliefs: child, and Beliefs:
vaccines & immunity)
9 (20%) 2 (3%)
Beliefs: others Beliefs about the
impact the child’s
vaccination status
on others outside
the family
Vaccinated: “I work in the healthcare
industry. All members of my family get
the flu vaccine every year. Because I
work with high risk patients, and there is
a chance that I might bring home the flu,
it makes sense to vaccinate. This provides
protection to my family, as well as
lowering the risk that I might bring an
illness to the patients that I work with on
a day to day basis.” (this comment also
coded as Beliefs: family)
2 (5%) 0 (0%)
Beliefs: flu Beliefs about
influenza, e.g.,
what it is and how
serious it is
Did not vaccinate: “The flu virus does not
appear to be that dangerous, an
inconvenience at most. Our child
generally hates doctors and medicines, so
it was just not that important.” (this
comment also coded as Beliefs: child)
Vaccinated: “Both myself and my children
get them every single year. My kids have
never had any negative side effects. I had
the flu once and I would never want my
children to experience that.” (this
comment also coded as Beliefs: child)
8 (18%) 3 (4%)
Beliefs: vaccines &
immunity
Beliefs about how
immunity occurs,
the role of
vaccines in
immunity, or
about vaccines
themselves
Vaccinated: “She was attending preschool
and colds seemed to circulate from one
child to another. I did it to give her added
immune protection.” (this comment also
coded as Beliefs: child)
(Continued)
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Table IV. Continued
Theme frequency among:
Theme Description Sample quotes
Participants who
vaccinated their
child against flu
(n = 44)
Participants who did
not vaccinate
their child against
flu (n = 70)
Did not vaccinate: “I believe in the power
of the immune system. If my child gets
the flu then she will develop the
antibodies to prevent it in the future. A
vaccine is no sure way of preventing the
varying strains of the flu. In my
experience the perpetual vaccination
process only makes for stronger viruses
that are more resistant in the future.”
(this comment also coded as Beliefs:
child)
Did not vaccinate: “I have always felt the
flu vaccine was unnecessary. A long time
ago my pediatrician told me he didn’t
think it was necessary and since then I
have never changed my mind. My
concern has always been that although
they vaccinate against the flu strain—
they don’t know which one will hit during
that year so it can’t vaccinate against the
current flu outbreak.”
Vaccinated: “I believe the vaccine does
help prevent the flu, and have seen it
myself where I was vaccinated, my wife
wasn’t, and she got the flu and I didn’t.
And that makes me even more
determined to get the flu shots.”
8 (18%) 27 (39%)
Logistics Comments that demonstrated the influence of the participant’s
circumstances on his or her decision to vaccinate or not vaccinate the
participant’s child against flu
4 (9%) 28 (40%)
Logistics that
interfered
Logistics that
actively interfered
with vaccination
Did not vaccinate: “I honestly couldn’t
afford it.”
Did not vaccinate: “I did not take him to
get the flu vaccine because it was difficult
to take off of work to bring him.”
Did not vaccinate: “I mentioned it to his
doctor but they said they didn’t have any.
I intended to bring him back but didn’t
get around to it.”
Not applicable 11 (16%)
Logistics that failed
to help
Logistics that failed
to help
vaccination but
did not actively
interfere
Did not vaccinate: “Normally they do the
vaccines at school and for some reason
they did not this year. . . . We honestly
just didn’t think about the vaccine on our
own since it is normally something the
school does.”
Did not vaccinate: “Honestly, we were so
busy that I just forgot. Nothing else. Not
my finest moment as a parent but
sometimes it happens.”
Not applicable 17 (24%)
(Continued)
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Table IV. Continued
Theme frequency among:
Theme Description Sample quotes
Participants who
vaccinated their
child against flu
(n = 44)
Participants who did
not vaccinate
their child against
flu (n = 70)
Logistics that
helped
Logistics that
actively helped
with vaccination
Vaccinated: “We got them the vaccine
because it was offered at Walgreens [a
large pharmacy chain in the U.S.]. I did
notice that they were not sick as often
this winter as they have been in the past.”
Vaccinated: “My child got the flu vaccine
mainly because it is a requirement to
attend public school districts, but I also
wanted to prevent all the nasty little
germs that children come home with
from making my household sick too.”
(also coded as Beliefs: family)
4 (9%) Not applicable
Table V. Themes (Follow-Up Survey)
Themes in response
Intended to have child
vaccinated against flu
Had child vaccinated
against flu n Beliefs only Logistics only Beliefs and logistics
No No 40 30 (75%) 6 (15%) 4 (10%)
No Yes 6 6 (100%) 0 (0%) 0 (0%)
Yes No 29 11 (38%) 17 (59%) 1 (3%)
Yes Yes 37 33 (89%) 2 (5%) 2 (5%)
used both a simple interface and a simple underlying
model. Further research is needed to investigate
whether, for example, more strategically designed
risk communication, more complex models, or
theoretically-based interfaces designed to support
more aspects of the decision-making process(29)
might have different effects. Another promising
avenue will involve investigating whether imple-
menting these kinds of interventions as part of a
clinical encounter using a shared decision-making
approach(6) might address challenges by supporting
parents and guardians in discussing their questions
with a trusted health-care professional.
4.2. Limitations
This study has several limitations. First, partici-
pants were recruited from an online pool of potential
survey participants and thus may not be representa-
tive of the broader population. We had difficulty re-
cruiting enough participants who met our inclusion
and exclusion criteria, and the rate of participation
in the follow-up study was lower than our original
aim of 50%. The long delay between the original sur-
vey and the follow-up survey may have contributed
to the difficulty in retention. In addition, because re-
cruitment was done via MTurk, it was difficult to re-
contact participants. Such difficulties in retention will
need to be addressed in future studies of this nature.
Because of the smaller sample than planned for the
follow-up study, its results must be interpreted with
caution.
Second, the risk and benefit information and
decision attributes used in the values clarification
exercise consisted only of those for which data were
available for risk estimates. This means that other
potentially important decision attributes, for exam-
ple, the out-of-pocket cost of the vaccine to a given
participant or the time required to take the child to
a location to receive the vaccine, were not integrated
into the risk-benefit information nor the values clar-
ification methods. Our qualitative analysis suggests
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that such barriers are important to at least some
people. In addition, the risk estimates are themselves
limited by our decision to privilege evidence for
which the full text would be freely available to all
study participants via a simple click (rather than, for
example, a relevant Cochrane review(58)) as well as
by the inherent uncertainty within scientific evidence.
Third, the original survey used values congru-
ence between stated values and vaccination inten-
tions as a secondary outcome. The follow-up survey
used a measure of informed choice that includes the
criterion that the final decision must be congruent
with one’s values. Values congruence is a key metric
of decision quality(30,31) but measuring it is problem-
atic because the mere act of asking questions about
values is a values clarification intervention in and of
itself. To avoid this problem to the greatest extent
possible, we framed the question very broadly—
asking about participants’ opinions of the risk-benefit
balance, not asking directly about their values for
different attributes of the options—and placed it
near the end of the original survey among fact-based
questions to help elicit an immediate answer rather
than a contemplative process. However, including
this question may have reduced our ability to detect
any effects of the experimental factor Values Clari-
fication in the follow-up study of actual vaccination
behavior.
Fourth and finally, as noted above, in our exper-
imental conditions, we presented the information in
as neutral and balanced a way as possible, in keep-
ing with international standards for patient decision
aids.(59) Our experimental methods made no univer-
sal recommendations and deliberately did not em-
phasize the importance of vaccination. Further, in the
original survey, we provided resources—such as fur-
ther information and a link to locations to get a flu
vaccine—to all participants, not just those in the in-
tervention groups. These features combined with the
smaller original sample size than planned and the low
response rate in the follow-up study meant that our
ability to detect effects of our experimental factors
on vaccination status and to incorporate other po-
tential moderators into our models were limited. The
promising results obtained despite these challenges
suggest that further work is needed to build upon this
preliminary study.
4.3. Conclusions
Current standard methods of providing parents
and guardians with information about childhood
influenza immunization may be improved by pro-
viding absolute estimates of risks and benefits.
Further, to support parents and guardians in making
informed choices about whether or not to vaccinate
their children against influenza, it may not be enough
to present information about risks and benefits well:
we may also need to help people align their choices
with their values. Higher intentions to vaccinate
were associated with our experimental methods, and
intentions significantly predicted rates of vaccina-
tion. Although there was no association between
our experimental methods and rates of vaccination
in this small sample, the results of this study are
encouraging for future research.
There is a philosophical tension between the po-
tential public good of vaccination and the individu-
alized principles of autonomy and informed choice.
Applying an approach that incorporates the detailed
communication of risk and benefits of vaccination
and an explicit method to help people understand
how their values are connected to their decision op-
tions is different frommany public health approaches
to vaccination. Our results support the contention
that methods of risk communication and values clar-
ification that have been shown to be helpful in other
clinical contexts may also be helpful in the context
of vaccination. Such techniques may hold the poten-
tial to serve both sides of the philosophical tension
by supporting individual informed choice while also
potentially leading to higher vaccination uptake.
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